Современные представления о таурине


DOI: https://dx.doi.org/10.18565/therapy.2020.3.128-136

А.С. Змитрукевич, А.Е. Копать

1 ГБУЗ «Городская поликлиника № 11 Департамента здравоохранения Москвы» филиал № 2; 2 Гродненский государственный медицинский университет, Беларусь, г. Гродно
Таурин – продукт обмена серосодержащих аминокислот – обладает целым рядом полезных свойств. Доказана цитопротекторная активность (нейропротекторные, гепатопротекторные, ретинопротекторные, нефропротекторные свойства и др.) этого соединения. Повышенный интерес представляет воздействие таурина на сердечно-сосудистую систему, включая гипотензивный эффект, а также его гипогликемическое действие, обусловленное защитой панкреатических бета-клеток, способностью индуцировать синтез инсулина и улучшением инсулинорезистентности. Среди прочих особенностей таурина можно выделить восстановление уровня триглицеридов, снижение уровня холестерина, антифиброзное и противоопухолевое действие, антиоксидантные свойства, противовоспалительную и антибактериальную активность.

Литература



  1. Анциферов М.Б. Роль таурина и его дефицита в организме человека и животных. Фарматека. 2012; 16: 60.

  2. Гавровская Л.К., Крылова И.Б., Сафонова А.Ф. с соавт. Влияние производных таурина на сердечно-сосудистую систему. Психофармакология и биологическая наркология

  3. Abd El-Twab S.M., Mohamed H.M., Mahmoud A.M. Taurine and pioglitazone attenuate diabetes-induced testicular damage by abrogation of oxidative stress and up-regulation of the pituitary-gonadal axis. 2016; 94(6): 651–61. doi: 10.1139/cjpp-2015-0503.

  4. Adedara I.A., Ojuade T.J.D., Olabiyi B.F. et al. Taurine ameliorates renal oxidative damage and thyroid dysfunction in rats chronically exposed to fluoride. Biol Trace Elem Res. 2017 Feb; 175(2): 388–95. doi: 10.1007/s12011-016-0784-2.

  5. Akande M.G., Shittu M., Uchendu C. et al. Taurine ameliorated thyroid function in rats co-administered with chlorpyrifos and lead. Vet Res Commun. 2016 Dec; 40(3–4): 123–129.

  6. Akande M.G., Aliu Y.O., Ambali S.F. et al. Taurine mitigates cognitive impairment induced by chronic co-exposure of male Wistar rats to chlorpyrifos and lead acetate. Environ Toxicol Pharmacol. 2014; 37(1): 315–25. doi: 10.1016/j.etap.2013.11.023.

  7. Capogrosso R.F., Cozzoli A., Mantuano P. et al. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. Pharmacol Res. 2016; 106: 101–113. doi: 10.1016/j.phrs.2016.02.016.

  8. Chen W., Guo J., Zhang Y. et al. The beneficial effects of taurine in preventing metabolic syndrome. Food Funct. 2016; 7(4): 1849–63. doi: 10.1039/c5fo01295c.

  9. Chesnoy-Marchais D. Persistent GABAA/C responses to gabazine, taurine and beta-alanine in rat hypoglossal motoneurons. Neuroscience. 2016; 330: 191–204. doi: 10.1016/j.neuroscience.2016.05.048.

  10. De Carvalho Bertozo L., Morgon N.H., De Souza A.R. et al. Taurine bromamine: reactivity of an endogenous and exogenous anti-inflammatory and antimicrobial amino acid derivative. Biomolecules. 2016; 6(1): 23. doi: 10.3390/biom6020023.

  11. Devi S.L., Viswanathan P., Anuradha C.V. Regression of liver fibrosis by taurine in rats fed alcohol: effects on collagen accumulation, selected cytokines and stellate cell activation. 2010; 637(1–3): 161–70. doi: 10.1016/j.ejphar.2010.08.011.

  12. Gu Y., Zhao Y., Qian K. et al. Taurine attenuates hippocampal and corpus callosum damage, and enhances neurological recovery after closed head injury in rats. Neuroscience. 2015; 291: 331–40. doi: 10.1016/j.neuroscience.2014.09.073.

  13. Hackett M.J., Paterson P.G., Pickering I.J. et al. Imaging taurine in the central nervous system using chemically specific X-ray fluorescence imaging at the sulfur K-edge. Anal Chem. 2016 Nov 15; 88(22): 10916–24.

  14. Hadj-Said W., Froger N., Ivkovic I. et al. Quantitative and topographical analysis of the losses of cone photoreceptors and retinal ganglion cells under taurine depletion. Invest Ophthalmol Vis Sci. 2016; 57(11): 4692–703. doi: 10.1167/iovs.16-19535.

  15. Hano T., Kasano M., Tomari H. et al. Taurine suppresses pressor response through the inhibition of sympathetic nerve activity and the improvement in baro-reflex sensitivity of spontaneously hypertensive rats. Adv Exp Med Biol. 2009; 643: 57–63.doi: 10.1007/978-0-387-75681-3_6.

  16. Han Z., Gao L.Y., Lin Y.H. et al. Neuroprotection of taurine against reactive oxygen species is associated with inhibiting NADPH oxidases. Eur J Pharmacol. 2016; 777: 129–35. doi: 10.1016/j.ejphar.2016.03.006.

  17. Heidari R., Jamshidzadeh A., Keshavarz N. et al. Mitigation of methimazole-induced hepatic injury by taurine in mice. 2014; 83(1): 143–58. doi: 10.3797/scipharm.1408-04.

  18. Heidari R., Rasti M., Shirazi Yeganeh B. et al. Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine. Bioimpacts. 2016; 6(1): 3–8. doi: 10.15171/bi.2016.01.

  19. Horvath G.A., Hukin J., Stockler-Ipsiroglu S.G. et al. Eye findings on vigabatrin and taurine treatment in two patients with succinic semialdehyde dehydrogenase deficiency. Neuropediatrics. 2016; 47(4): 263–67. doi: 10.1055/s-0036-1583183.

  20. Hu J., Xu X., Yang J. et al. Antihypertensive effect of taurine in rat. Adv Exp Med Biol. 2009; 643: 75–84.doi: 10.1007/978-0-387-75681-3_8.

  21. Ideishi M., Miura S., Sakai T. et al. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens. 1994; 12(6): 653–61.

  22. Ito T., Schaffer S., Azuma J. The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. Amino Acids. 2014; 46(1): 111–19. doi: 10.1007/s00726-013-1507-z.

  23. Nerbonne J.M., Kass R.S. Molecular physiology of cardiac repolarization. Physiological Reviews. 2005 Oct; 85(4): 1205–53.

  24. Katakawa M., Fukuda N., Tsunemi A. et al. Taurine and magnesium supplementation enhances the function of endothelial progenitor cells through antioxidation in healthy men and spontaneously hypertensive rats. Hypertens Res. 2016 Dec; 39(12): 848–56. doi: 10.1038/hr.2016.86.

  25. Khimsuksri S., Wyss J.M., Thaeomor A. et al. Perinatal taurine exposure programs patterns of autonomic nerve activity responses to tooth pulp stimulation in adult male rats. Adv Exp Med Biol. 2013; 775: 121–34. doi: 10.1007/978-1-4614-6130-2_10.

  26. Lee S.Y. et al. Effects of S-adenosylmethionine and its combinations with taurine and/or betaine on glutathione homeostasis in ethanol-induced acute hepatotoxicity. J Cancer Prev. 2016; 21(3): 164–72.

  27. Lee S.Y., Ko K.S. Protective Effects of S-Adenosylmethionine and its combinations with taurine and/or betaine against lipopolysaccharide or polyinosinic-polycytidylic acid-induced acute hepatotoxicity. J Cancer Prev. 2016; 21(3): 152–63.

  28. Lerdweeraphon W., Wyss J.M., Boonmars T. et al. Perinatal taurine depletion alters the renal excretory effect of the Renin-Angiotensin system in adult female rats. Adv Exp Med Biol. 2015; 803: 679–91. doi: 10.1007/978-3-319-15126-7_54.

  29. Liin S.I., Larsson J.E., Barro-Soria R. et al. Fatty acid analogue N-Arachidonoyl taurine restores function of IKs channels with diverse long QT mutations. Elife. 2016 Sep 30; 5. pii: e20272. doi: 10.7554/eLife.20272.

  30. Lin C., Zhao Y., Wan G. et al. Effects of simvastatin and taurine on delayed cerebral vasospasm following subarachnoid hemorrhage in rabbits. Exp Ther Med. 2016; 11(4): 1355–60.

  31. Marcinkiewicz J., Kontny E. Taurine and inflammatory diseases. Amino Acids. 2014; 46(1): 7–20. doi: 10.1007/s00726-012-1361-4.

  32. Marcinkiewicz J., Wojas-Pelc A., Walczewska M. et al. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study. Eur J Dermatol. 2008; 18(4): 433–39. doi: 10.1684/ejd.2008.0460.

  33. Matsubara K., Mori H., Hirai N. et al. Elevated taurine and glutamate in cerebral juvenile xanthogranuloma on MR spectroscopy. Brain Dev. 2016; 38(10): 964–67. doi: 10.1016/j.braindev.2016.07.001.

  34. Mizushima S., Nara Y., Sawamura M. et al. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol. 1996; 403: 615–22.

  35. Omura Y., Lu D., Jones M.K. et al. Optimal dose of vitamin D3 400 I.U. for average adults has a significant anti-cancer effect, while widely used 2000 I.U. or higher promotes cancer: marked reduction of taurine & 1α, 25(OH)2D3 was found in various cancer tissues and oral intake of optimal dose of taurine 175mg for average adults, rather than 500mg, was found to be a new potentially safe and more effective method of cancer treatment. Acupunct Electrother Res. 2016; 41(1): 39–60.

  36. Owoyele B.V., Oyewole A.L., Biliaminu S.A. et al. Effect of taurine and caffeine on plasma C-reactive protein and calcium in Wistar rats. Afr J Med Med Sci. 2015; 44(3): 229–36.

  37. Ozsarlak-Sozer G., Sevin G., Ozgur H.H. et al. Diverse effects of taurine on vascular response and inflammation in GSH depletion model in rabbits. Eur Rev Med Pharmacol Sci. 2016; 20(7): 1360–72.

  38. Rahmeier F.L., Zavalhia L.S., Tortorelli L.S. et al. The effect of taurine and enriched environment on behaviour, memory and hippocampus of diabetic rats. Neurosci Lett. 2016; 630: 84–92. doi: 10.1016/j.neulet.2016.07.032.

  39. Ribeiro R.A., Santos-Silva J.C., Vettorazzi J.F. et al. Taurine supplementation enhances insulin secretion without altering islet morphology in non-obese diabetic mice. Adv Exp Med Biol. 2015; 803: 353–70. doi: 10.1007/978-3-319-15126-7_27.

  40. Robb W.B., Condron C., Moriarty M. et al. Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice. Ir J Med Sci. 2010; 179(1): 99–105. doi: 10.1007/s11845-009-0389-2.

  41. Rosca A.E. Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats. Braz J Med Biol Res. 2016; 49(6): 5116.

  42. Roysommuti S., Thaeomor A., Khimsuksri S. et al. Perinatal taurine imbalance alters the interplay of renin-angiotensin system and estrogen on glucose-insulin regulation in adult female rats. Adv Exp Med Biol. 2013; 776: 67–80. doi: 10.1007/978-1-4614-6093-0_8.

  43. Roysommuti S., Kritsongsakchai A., Wyss J.M. The effect of perinatal taurine on adult renal function does not appear to be mediated by taurine’s inhibition of the renin-angiotensin system. Adv Exp Med Biol. 2015; 803: 665–77. doi: 10.1007/978-3-319-15126-7_53.

  44. Ruan Y., Li M., Wang T. et al. Taurine supplementation improves erectile function in rats with streptozotocin-induced type 1 diabetes via amelioration of penile fibrosis and endothelial dysfunction. J Sex Med. 2016; 13(5): 778–85. doi: 10.1016/j.jsxm.2016.02.164.

  45. Santos-Silva J.C., Ribeiro R.A., Vettorazzi J.F. et al. Taurine supplementation ameliorates glucose homeostasis, prevents insulin and glucagon hypersecretion, and controls β, α, and δ-cell masses in genetic obese mice. Amino Acids. 2015; 47(8): 1533–48. doi: 10.1007/s00726-015-1988-z.

  46. Terrill J.R., Grounds M.D., Arthur P.G. Increased taurine in pre-weaned juvenile mdx mice greatly reduces the acute onset of myofibre necrosis and dystropathology and prevents inflammation. PLoS Curr. 2016 Apr 29; 8. pii: ecurrents.md.77be6ec30e8caf19529a00417614a072. doi: 10.1371/currents.md.77be6ec30e8caf19529a00417614a072.

  47. Vang S., Longley K., Steer C.J. et al. The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases. Glob Adv Health Med. 2014; 3(3): 58–69. doi: 10.7453/gahmj.2014.017.

  48. Vettorazzi J.F., Ribeiro R.A., Santos-Silva J.C. et al. Taurine supplementation increases K(ATP) channel protein content, improving Ca2+ handling and insulin secretion in islets from malnourished mice fed on a high-fat diet. Amino Acids. 2014; 46(9): 2123–36. doi: 10.1007/s00726-014-1763-6.

  49. Vettorazzi J.F., Ribeiro R.A., Borck P.C. et al. The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreaticbeta cells. Metabolism. 2016; 65(3): 54–63. doi: 10.1016/j.metabol.2015.10.021.

  50. Wang B. OS 12-04 taurine supplementation lowers blood pressure and reduces carotid intima-media thickness in prehypertension. J Hypertens. 2016; 34(1): E. 76–77. doi: 10.1097/01.hjh.0000500052.97958.32.

  51. Wang Q., Fan W., Cai Y. et al. Protective effects of taurine in traumatic brain injury via mitochondria and cerebral blood flow. Amino Acids. 2016; 48(9): 2169–77. doi: 10.1007/s00726-016-2244-x.

  52. Wang Y., Mei X., Yuan J. et al. Taurine zinc solid dispersions enhance bile-incubated L02 cell viability and improve liver function by inhibiting ERK2 and JNK phosphorylation during cholestasis. Wang Toxicology. 2016 Jul 29; 366–367: 10–19. doi: 10.1016/j.tox.2016.07.015.

  53. Weiss S.J., Test S.T., Eckmann C.M. et al. Brominating oxidants generated by human eosinophils. Science. 1986; 234(4773): 200–03.

  54. Worden J.A., Stipanuk M.H. A comparison by species, age and sex of cysteinesulfinate decarboxylase activity and taurine concentration in liver and brain of animals. Comp Biochem Physiol B. 1985; 82(2): 233–39.

  55. Yang L., Tang J., Chen H. et al. Taurine reduced epidural fibrosis in rat models after laminectomy via downregulating EGR1. Cell Physiol Biochem. 2016; 38(6): 2261–71. doi: 10.1159/000445581.

  56. Yu Y.R., Ni X.Q., Huang J. et al. Taurine drinking ameliorates hepatic granuloma and fibrosis in mice infected with Schistosoma japonicum. Int J Parasitol Drugs Drug Resist. 2016; 6(1): 35–43. doi: 10.1016/j.ijpddr.2016.01.003.

  57. Zhang Y., Li D., Li H. et al. Taurine pretreatment prevents isoflurane-induced cognitive impairment by inhibiting ER stress-mediated activation of apoptosis pathways in the hippocampus in aged rats. Neurochem Res. 2016; 41(10): 2517–25.

  58. Zheng Y., Ceglarek U., Huang T. et al. Plasma taurine, diabetes genetic predisposition, and changes of insulin sensitivity in response to weight-loss diets. J Clin Endocrinol Metab. 2016; 101(10): 3820–26.

  59. Zhu X.Y., Ma P.S., Wu W. et al. Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats. Brain Res Bull. 2016; 124: 295–305. doi: 10.1016/j.brainresbull.2016.06.010.


Об авторах / Для корреспонденции


Андрей Станиславович Змитрукевич, врач-терапевт ГБУЗ «Городская поликлиника № 11 Департамента здравоохранения Москвы», филиал № 2. Адрес: 119311, Москва, пр-кт Вернадского, д. 9/10. Тел.: 8 (925) 825-06-18. E-mail: andrey1881889@gmail.com
Анастасия Евгеньевна Копать, ассистент кафедры биологической химии УО «Гродненский государственный медицинский университет». Адрес: Республика Беларусь, 230009, г. Гродно, ул. Максима Горького, д. 80.
Тел.: +375 (29) 204-38-22. E-mail: kopats_93@mail.ru


Похожие статьи


Бионика Медиа